Filing Flows › Bionano Genomics (BNGO) › Product revenue
Bionano Genomics (BNGO) Product revenue by quarter
Bionano Genomics' Product revenue was $7.7M in Q2 2026 (second quarter 2026), +26% from Q1 2026. Over the last 5 quarters it ranged from $6.0M (Q1 2025) to $7.7M (Q2 2026).
| Quarter | Product revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $7.7M | +26% | +22% |
| Q1 2026 | $6.1M | -12% | +1% |
| Q3 2025 | $6.9M | +10% | — |
| Q2 2025 | $6.3M | +5% | — |
| Q1 2025 | $6.0M | — | — |
Q2 2026 at a glance
Bionano Genomics, Q2 2026: revenue $8.2M (+21% year over year), operating margin -88.3%, net loss $7.4M, operating cash flow −$4.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bionano Genomics' Product revenue?
Bionano Genomics' Product revenue was $7.7M in Q2 2026 (second quarter 2026), +26% from Q1 2026.
How has Bionano Genomics' Product revenue changed?
Over the last 5 quarters it ranged from $6.0M (Q1 2025) to $7.7M (Q2 2026).